ARCHIVES

Congressional News: Senate To NIH: Administrative Offices Should Consolidate

This article is from The Cancer Letter archive.

Vol. 22 No. 36 | September 20, 1996

Download PDF Visit The Full Archive

Related Articles

Nine More Reported In Range Of CCOP 3 Recompetition

February 2, 1990

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

July 28, 1989

RFA On Promoters, Hormones, Other Cofactors Available

July 17, 1981

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

Master’s Program In Nurse Oncology Kept Alive; Final Decisions In February

October 21, 1977

Senate Bill Would Prohibit Political Appointments To Advisory Groups

January 9, 1976